fosinopril - Medical Dictionary

Home | fosinopril - Medical Dictionary |


fosinopril		A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. [ Books \| Images \| Discussion groups ]

Additional comments : (Dynacil, Fosinopril Sodium, Fozitec, Monopril, Staril, Tenso Stop, Tensocardil) Pharmacologic Action: Angiotensin-Converting Enzyme Hypertension ▼ Malignant Hypertension Pregnancy-Induced Hypertension Renal Hypertension Articles Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. Authors: Pilote L, Abrahamowicz M, Eisenberg M, Humphries K, Behlouli H, Tu JV Journal: CMAJ Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Authors: Nayak V, Patil PA Journal: Indian J Exp Biol Differential Response in Left Ventricular Mass and Arterial Resistive Index following Fosinopril Therapy. Authors: Veglio F, Gastaldi L, Frascisco M, Coda L, Melchio R, Rabbia F, Chiandussi L Journal: Clin Drug Investig Tolerability and efficacy of fosinopril and hydrochlorothiazide compared with amiloride and hydrochlorothiazide in patients with mild to moderate hypertension. Authors: Saini R, Romanini M, Mos L Journal: Clin Drug Investig A comparison of fosinopril and hydrochlorothiazide with hydrochlorothiazide in non-insulin-dependent diabetes mellitus patients with mild to moderate hypertension. Authors: Saini R, Romanini M, Veglio F Journal: Clin Drug Investig Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Authors: Basi S, Fesler P, Mimran A, Lewis JB Journal: Diabetes Care Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase. Authors: Tao X, Zhang YJ, Shen FM, Guan YF, Su DF Journal: J Cardiovasc Pharmacol Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects. Authors: van de Wal RM, van der Harst P, Gerritsen WB, van der Horst F, Plokker TH, Gansevoort RT, van Gilst WH, Voors AA Journal: J Renin Angiotensin Aldosterone Syst Monitoring of fosinopril sodium impurities by liquid chromatography-mass spectrometry including the neural networks in method evaluation. Authors: Janci? B, Medenica M, Ivanovi? D, Jankovi? S, Malenovi? A Journal: J Chromatogr A [Observation on therapeutic effects of combined acupuncture and medicine therapy and simple medication on renal hypertension of chronic kidney disease] Authors: Song YH Journal: Zhongguo Zhen Jiu Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats. Authors: El-Demerdash E, Salam OM, El-Batran SA, Abdallah HM, Shaffie NM Journal: Clin Exp Pharmacol Physiol Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease. Authors: Gogovor A, Dragomir A, Savoie M, Perreault S Journal: Value Health Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins. Authors: Li P, Yan J, Sun Y, Burczynski FJ, Gong Y Journal: Nephrology (Carlton) [Effects of fosinopril on proliferation and secretion of extracellular matrix of rat glomerular mesangial cell] Authors: Hao ZH, Yu L, Wang LN, Weng ZY, Zhang L, Zhao D, Zhang YX Journal: Zhonghua Er Ke Za Zhi Cardiac treatment in neuro-muscular diseases. Authors: Nigro G, Politano L, Passamano L, Palladino A, De Luca F, Nigro G, Comi LI Journal: Acta Myol Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Authors: Kessler M, Zannad F, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz A, Lechat P, Journal: Nephrol Dial Transplant [Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome] Authors: Simonenko VB, Medvedev IN, Tolmachev VV Journal: Klin Med (Mosk) Heart Rate Variability and Baroreflex Sensitivity during Fosinopril, Irbesartan and Atenolol Therapy in Hypertension. Authors: Rabbia F, Silke B, Carra R, Milan A, Del Colle S, Pugni C, Mulatero P, Chiandussi L, Veglio F Journal: Clin Drug Investig Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma. Authors: Cui S, Feng F, Ma M, Liu H, Chen Y Journal: J Chromatogr B Analyt Technol Biomed Life Sci Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty. Authors: Zhao JL, Yang YJ, Zhang YH, Pei WD, Sun YH, Chen JL, Gao RL Journal: Clin Cardiol Transient recurrent ascites. Authors: Kahegeshe NL, Pestiaux A, Henry JP, van Cauter J Journal: Acta Gastroenterol Belg [Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of Qi-yin deficiency syndrome type] Authors: Chen XM, Chen YP, Chen J Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy. Authors: Sultana N, Arayne MS, Sana A Journal: Pak J Pharm Sci Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. Authors: Zheng Z, Chen H, Xu X, Li C, Gu Q Journal: Exp Eye Res [Fosinopril but not metoprolol attenuated the increased matrix metallo-proteinases 9 expression at mRNA and protein levels of human umbilical vein endothelial cells exposed to oscillatory flow] Authors: Cheng WL, Ke YN, Wang Y, Chen L, Fan SY Journal: Zhonghua Xin Xue Guan Bing Za Zhi Images in emergency medicine. Angioedema as a result of angiotensin-converting enzyme inhibitor. Authors: Alkhatib AA, Bhattacharjee M Journal: Ann Emerg Med [Prospective, multi-centered, randomized and controlled trial on effect of Shenle Capsule in treating patients with IgA nephropathy of Fei-Pi qi-deficiency syndrome] Authors: Chen XM, Chen YP, Zhou ZL Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi [Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril] Authors: García-Testal A, Monzó A, Rabanaque G, González A, Romeu A Journal: Med Clin (Barc) Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. Authors: Asselbergs FW, van der Harst P, van Roon AM, Hillege HL, de Jong PE, Gans RO, Smit AJ, van Gilst WH Journal: Atherosclerosis Primary hyperaldosteronism in a patient with end-stage renal disease. Authors: Kazory A, Weiner ID Journal: Nephrol Dial Transplant Demonstration of functional dipeptide transport with expression of PEPT2 in guinea pig cardiomyocytes. Authors: Lin H, King N Journal: Pflugers Arch [Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure] Authors: Otasevi? P, Putinikovi? B, Vukajlovi? Z, Ilisi? B, Neskovi? AN Journal: Med Pregl Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex. Authors: He H, Wang W, Zhang H, Ma L, Wu H, Wang P, Gao J Journal: Cardiovasc Drugs Ther Clinical study on effect of Garlicin in stabilizing the carotid artery atherosclerotic plaque in patients with primary hypertension and coronary artery disease. Authors: Cheng WL, Ke YN, Shi ZX, Wang Y, Chen L, Ju G, Fan SY Journal: Chin J Integr Med Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients. Authors: van de Wal RM, Gansevoort RT, van der Harst P, Boomsma F, Thijs Plokker HW, van Veldhuisen DJ, de Jong PE, van Gilst WH, Voors AA Journal: Hypertension C-reactive protein (CRP)-lowering agents. Authors: Prasad K Journal: Cardiovasc Drug Rev [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients] Authors: Tasi? IS, Mijalkovi? D, Djordjevi? D, Lovi? B, Jankovi? D, Miladinovi?-Tasi? N, Lovi? M Journal: Srp Arh Celok Lek Racial differences are seen in blood pressure response to fosinopril in hypertensive children. Authors: Menon S, Berezny KY, Kilaru R, Benjamin DK, Kay JD, Hazan L, Portman R, Hogg R, Deitchman D, Califf RM, Li JS Journal: Am Heart J [Evaluation of the effectivenes of treatment of patients with renal arterial hypertension with carvedilol] Authors: Rakov AL, Nikitin AV, Riabov AIu Journal: Klin Med (Mosk) Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Authors: Zannad F, Kessler M, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz A, Lechat P Journal: Kidney Int [Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy] Authors: Dimkovi? N, Djordjevi? T, Popovi? J, Dimkovi? S, Tirmenstajn-Jankovi? B, Zivanovi? M, Bobanovi?-Haskovi? J Journal: Srp Arh Celok Lek Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion. Authors: Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Cheng JL, Gao RL Journal: Coron Artery Dis Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats. Authors: Zhang L, Ma J, Gu Y, Lin S Journal: Nephron Exp Nephrol Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Authors: Yi Z, Li Z, Wu XC, He QN, Dang XQ, He XJ Journal: Pediatr Nephrol [Did a reform strategy in drug management improve doctors' prescribing habits in Montenegro: the example for the cardiovascular drugs] Authors: Duborija-Kovacevi? N, Tomi? Z Journal: Vojnosanit Pregl Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Authors: Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ, Journal: Clin Ther The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Authors: Atthobari J, Brantsma AH, Gansevoort RT, Visser ST, Asselbergs FW, van Gilst WH, de Jong PE, de Jong-van den Berg LT, Journal: Nephrol Dial Transplant Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center. Authors: Gates R, Cookson T, Ito M, Marcus D, Gifford A, Le TN, Nguyen CN Journal: Am J Health Syst Pharm Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy. Authors: Lou T, Wang C, Chen Z, Shi C, Tang H, Liu X, Yin P, Yu X Journal: Nephrology (Carlton) The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency. Authors: Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC Journal: Diabetes Obes Metab Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Authors: Van Antwerpen P, Legssyer I, Zouaoui Boudjeltia K, Babar S, Moreau P, Moguilevsky N, Vanhaeverbeek M, Ducobu J, Nève J Journal: Eur J Pharmacol Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Authors: Hodson EM, Habashy D, Craig JC Journal: Cochrane Database Syst Rev [Effect of fosinopril on some parameters of endothelial function in patients with metabolic syndrome] Authors: Gil'mutdinova LT, Syrtlanova ER, Sharapova SP Journal: Kardiologiia [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?] Authors: Fomin VV, Moiseev SV Journal: Kardiologiia [Microalbuminuria--an independent indication for administration of ACE inhibitors: role of fosinopril (PREVEND IT trial)] Authors: Journal: Ter Arkh Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate. Authors: Foster J, Reisman W, Lepage N, Filler G Journal: Pediatr Nephrol Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support. Authors: Janci B, Medenica M, Ivanovi? D, Malenovi? A, Markovi? S Journal: Anal Bioanal Chem Synthesis of optically active trans 4-cyclohexyl-L-proline as an intermediate product in the preparation of fosinopril. Authors: Kalisz D, Dabrowski Z, Kakol B, Be?dowicz M, Obukowicz B, Kami?ski J Journal: Acta Pol Pharm Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent. Authors: Jancic B, Ivanovic D, Medenica M, Malenovic A, Dimkovic N Journal: J Chromatogr A [Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)] Authors: Belenkov IuN, Belianko IE, Gerasimova VV, Dolotov VK, Konstantinov BA, Koroteev AV, Kulagina TIu, Mareev VIu, Rebunenkov GV, Sandrikov VA, Skvortsov AA, Sychev AV, Tereshchenko SN, Khovrin VV Journal: Kardiologiia [Beneficial effects of fosinopril on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion] Authors: Zhao JL, Yang YJ, Jing ZC, Wu YJ, You SJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ Journal: Zhonghua Xin Xue Guan Bing Za Zhi For potential resolution of cough associated with an angiotensin-converting enzyme inhibitor. Authors: Eledrisi M, Alamoudi R Journal: Endocr Pract [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase] Authors: Zhang RY, Huang YL, Sun YH Journal: Zhonghua Yi Xue Za Zhi Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk. Authors: Voors AA, de Kam PJ, van den Berg MP, Borghi C, Hochman JS, van Veldhuisen DJ, van Gilst WH Journal: Cardiovasc Drugs Ther [Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia] Authors: Vershinina AM, Gapon LI, Veber EE, Popova SN, Pliusnin AV Journal: Ter Arkh [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats] Authors: Wei M, Gu SM, Zhang YY, Wu YH, Wu ZG Journal: Zhonghua Xin Xue Guan Bing Za Zhi [A clinical intervention study among 463 essential hypertensive patients with metabolic syndrome] Authors: Guo JZ, Gong YC, Zhang JL, Qing YW, Dai QY, Wang YC, Gao X, Ni YF Journal: Zhonghua Xin Xue Guan Bing Za Zhi [Applicability of fozinopril for correction of basic manifestations of metabolic syndrome in women with arterial hypertension] Authors: Logacheva IV, Shustova EN, Morozova NI Journal: Ter Arkh Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension. Authors: Bilge AK, Atilgan D, Tükek T, Ozcan M, Ozben B, Koylan N, Meriç M Journal: Int J Clin Pract Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial. Authors: Geluk CA, Asselbergs FW, Hillege HL, Bakker SJ, de Jong PE, Zijlstra F, van Gilst WH Journal: Eur Heart J Early outcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic heart failure. Authors: Schofield RS, Kline SE, Schmalfuss CM, Carver HM, Aranda JM, Pauly DF, Hill JA, Neugaard BI, Chumbler NR Journal: Telemed J E Health Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril. Authors: Zhang W, Chen X, Shi S, Wei R, Wang J, Yamanaka N, Hong Q Journal: Nephrol Dial Transplant Heart failure and first dose hypotension after angiotensin converting enzyme inhibitors. Authors: Vítovec J, Spinar J Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub [Changes of collagen expression of pulmonary arteries and heart ventricles and intervention of fosinopril and losartan in rats with heart failure] Authors: Wu ZJ, He JG, Li L, Li YH, Cheng XS, Ruan YM, Liu GZ Journal: Zhonghua Yi Xue Za Zhi Lithium toxicity after switch from fosinopril to lisinopril. Authors: Meyer JM, Dollarhide A, Tuan IL Journal: Int Clin Psychopharmacol Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria. Authors: Asselbergs FW, van Roon AM, Hillege HL, de Jong PE, Gans RO, Smit AJ, van Gilst WH, Journal: Stroke [Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure] Authors: Berezin AE Journal: Klin Med (Mosk) [Effects of carvedilol, atenolol and their combination with fosinopril on cardiac rhythm variability, clinicofunctional status and quality of life in patients with postinfarction left ventricular dysfunction] Authors: Tepliakov AT, Popov SV, Kaliuzhin VV, Garganeeva AA, Kurlov IO, Nilogov VL, Rybal'chenko EV, Shilov SN Journal: Ter Arkh Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial. Authors: Zanchetti A, Crepaldi G, Bond MG, Gallus G, Veglia F, Mancia G, Ventura A, Baggio G, Sampieri L, Rubba P, Sperti G, Magni A, Journal: Stroke Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Authors: Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH, Journal: Circulation Framingham score and microalbuminuria: combined future targets for primary prevention? Authors: Asselbergs FW, Hillege HL, van Gilst WH Journal: Kidney Int Suppl A unique form of polycythemia associated with minimal change disease. Authors: Balal M, Seyrek N, Karayaylali I, Paydas S Journal: Med Princ Pract Comparative effects of fosinopril and irbesartan on hematopoiesis in essential hypertensives. Authors: Robles NR, Angulo E, Grois J, Barquero A Journal: Ren Fail Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports). Authors: Jian-Liang Z, Yong-Wen Q, Xing Z, Jian-Li Q, Jiang C, Rong-Liang X Journal: Diabetes Res Clin Pract Fosinopril and amlodipine in the treatment of isolated systolic hypertension. Authors: Pavlovi? K, Benc D, Kmezi?-Grujin J, Stojiljkovi? J, Cemerli?-Adi? N, Miljkovi? T, Mesaros P Journal: Med Pregl Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. Authors: Rosenson RS, Reasner CA Journal: Curr Opin Cardiol Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. Authors: Coletta AP, Cleland JG, Freemantle N, Clark AL Journal: Eur J Heart Fail Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Authors: Li JS, Berezny K, Kilaru R, Hazan L, Portman R, Hogg R, Jenkins RD, Kanani P, Cottrill CM, Mattoo TK, Zharkova L, Kozlova L, Weisman I, Deitchman D, Califf RM Journal: Hypertension Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Authors: Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E Journal: Ann Intern Med Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats. Authors: el-Batran SA, el-Shenawy SM, Nofal SM, Abdel-Salam OM, Arbid MS Journal: Pharmacol Res American Heart Association scientific sessions. Authors: Winkelmann BR Journal: Expert Opin Investig Drugs Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril. Authors: Pfützner W, Ruëff F, Przybilla B Journal: Acta Derm Venereol Comparison of dipyridamole and fosinopril on renal progression in nephrectomized rats. Authors: Buranakarl C, Kitjtawonrat A, Pondeenana S, Sunyasujaree B, Kanchanapangka S, Chaiyabutr N, Bovee KC Journal: Nephrology (Carlton) Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action. Authors: Yu CM, Wing-Hon Lai K, Li PS, Lam KY, Leung JC, Lai KN Journal: J Mol Cell Cardiol Role of Angiotensin-converting enzyme and neutral endopeptidase in flow-dependent remodeling. Authors: Korshunov VA, Massett MP, Carey RM, Berk BC Journal: J Vasc Res Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats. Authors: Mifsud SA, Burrell LM, Kubota E, Jaworski K, Cooper ME, Wilkinson-Berka JL Journal: Clin Exp Hypertens Protection of organic trauma in sinoaortic-denervated rats treated with fosinopril. Authors: Tao X, Liu GL Journal: Yao Xue Xue Bao Introduction to monitoring. What is what you prescribed actually doing? Authors: Shakib S, George A Journal: Aust Fam Physician Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Authors: Pu Q, Larouche I, Schiffrin EL Journal: Am J Hypertens Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. Authors: Lods N, Ferrari P, Frey FJ, Kappeler A, Berthier C, Vogt B, Marti HP Journal: J Am Soc Nephrol

Back